{"nct_id":"NCT00500539","title":"Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation.","status":"COMPLETED","status_verified_date":"2011-05","start_date":"2007-07","start_date_type":null,"primary_completion_date":"2008-09","primary_completion_date_type":"ACTUAL","completion_date":"2008-09","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}